Flagship Ventures 2007 General Partner LLC
SEC-identified person · CIK 1508053 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Transmedics Group, Inc. TMDX | Officer | filed 2019 - 2019 |
| Axcella Health Inc. AXLA | Officer | filed 2019 - 2019 |
| Kaleido Biosciences, Inc. KLDO | Officer | filed 2019 - 2019 |
| Sesen Bio, Inc. SESN | Officer | filed 2014 - 2016 |
| Selecta Biosciences INC SELB | Director | filed 2016 - 2016 |
| Seres Therapeutics, Inc. MCRB | Officer | filed 2015 - 2016 |
| BG Medicine, Inc. BGMD | Officer | filed 2015 - 2015 |
| Agios Pharmaceuticals, INC. AGIO | Officer | filed 2013 - 2014 |
| Receptos, Inc. RCPT | Officer | filed 2013 - 2013 |
| Tetraphase Pharmaceuticals INC TTPH | Officer | filed 2013 - 2013 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.